About this document
Evidence Based Medicin: Is The Use of Dolutegravir Containing Regimen Considered Safe in Pregnancy? by mwaisangolusako16 is a document available to read on EtoBox.
The document discusses the safety of Dolutegravir (DTG) in HIV-positive pregnant women, highlighting concerns about neural tube defects (NTDs) associated with its use. Recent studies suggest that while DTG may be linked to NTDs, adequate folate supplementation can mitigate this risk, and the benefits of DTG, such as effective viral suppression and lower transmission rates, outweigh potential risks. Recommendations vary based on pregnancy status and fertility intentions, emphasizing DTG
- Author
- mwaisangolusako16
- Language
- EN